Valuation: Acarix AB

Market Cap 30Cr 3.13Cr 2.74Cr 2.52Cr 2.33Cr 4.42Cr 298.42Cr 4.5Cr 12Cr 147.01Cr 12Cr 11Cr 505.39Cr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 30Cr 3.13Cr 2.74Cr 2.52Cr 2.33Cr 4.42Cr 298.42Cr 4.5Cr 12Cr 147.01Cr 12Cr 11Cr 505.39Cr EV / Sales 2026 *
15.8x
EV / Sales 2027 * 4.34x
Free-Float
80.16%
Yield 2026 *
-
Yield 2027 * -
1 day-1.17%
1 week-0.59%
Current month-0.20%
1 month-3.79%
3 months-13.75%
6 months-4.15%
Current year-5.22%
1 week 0.24
Extreme 0.2435
0.26
1 month 0.24
Extreme 0.242
0.27
Current year 0.22
Extreme 0.2245
0.33
1 year 0.22
Extreme 0.2245
0.47
3 years 0.17
Extreme 0.1688
0.6
5 years 0.17
Extreme 0.1688
1.87
10 years 0.17
Extreme 0.1688
26.8
Manager TitleAgeSince
Chief Executive Officer - 01/02/2024
Chief Executive Officer 62 23/02/2018
Director TitleAgeSince
Director/Board Member 61 01/01/2020
Director/Board Member 52 14/05/2024
Director/Board Member - 14/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
-1.17%-0.59%-35.86%-54.80% 3.13Cr
+3.73%+6.80%+9.75%-22.36% 1.73TCr
+3.87%-5.71%+14.03%+89.94% 168.39Cr
+4.76%+0.11%-39.78%-78.85% 124.58Cr
-2.75%-6.73%-32.28%+29.11% 106.09Cr
+2.92%-2.22%-29.25%-54.48% 63Cr
+3.91%-4.74%-39.86%-57.02% 55Cr
+2.60%+4.15%+35.25%-52.31% 47Cr
+1.13%-0.48%-54.86%-58.92% 38Cr
+2.67%-5.46%-24.37%-24.54% 34Cr
Average +2.17%-0.85%-19.72%-28.42% 236.76Cr
Weighted average by Cap. +3.40%+4.43%+2.28%-17.95%

Financials

2026 *2027 *
Net sales 1.91Cr 19.81L 17.33L 15.99L 14.76L 28.01L 19Cr 28.49L 75.01L 9.31Cr 74.39L 72.78L 32Cr 6.95Cr 72.1L 63.06L 58.17L 53.72L 1.02Cr 69Cr 1.04Cr 2.73Cr 34Cr 2.71Cr 2.65Cr 116.45Cr
Net income -2.89Cr -29.98L -26.22L -24.19L -22.34L -42.39L -29Cr -43.1L -1.13Cr -14Cr -1.13Cr -1.1Cr -48Cr 24L 2L 2L 2L 2L 4L 2.37Cr 4L 9L 1.17Cr 9L 9L 4.02Cr
Net Debt - -
Logo Acarix AB
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Employees
8
Date Price Change Volume
10/26/10 SEK 0.2540 -1.17% 80,519
09/26/09 SEK 0.2570 +0.39% 7,70,882
08/26/08 SEK 0.2560 +2.40% 8,38,207
07/26/07 SEK 0.2500 -2.34% 10,26,959
06/26/06 SEK 0.2560 +0.20% 1,84,476

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ACARIX Stock